Stock VLA VIRALYTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Viralytics Ltd. Stock

Equities

VLA

AU000000VLA6

Biotechnology & Medical Research

Chart Viralytics Ltd.

Dynamic Chart

Latest news about Viralytics Ltd.

Amgen : Merck to buy virus-based cancer drug firm Viralytics for $394 million RE
More news

Analyst Recommendations on Viralytics Ltd.

Viralytics : ROTH Capital Partners - Updated Research Note PU
More recommendations

Press releases Viralytics Ltd.

Viralytics : Chairman’s letter to shareholders PU
Viralytics : New Data Presented at SITC Annual Meeting PU
Viralytics : Annual Report and Full Year Financial Results PU
Viralytics : Newsletter PU
Viralytics : Positive Bio-Marker Data from CANON Study PU
More press releases

News in other languages on Viralytics Ltd.

Immunothérapie: Merck & Co achète l'australien Viralytics
More news

Managers and Directors - Viralytics Ltd.

Managers TitleAgeSince
Georgina Diab SEC
 Corporate Secretary - 18-06-19
Jennifer Rosenthal PRN
 Corporate Officer/Principal - -
More insiders

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.62% 105B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+3.85% 97.5B
ARGENX SE Stock argenx SE
+1.86% 22.19B
BIONTECH SE Stock BioNTech SE
-16.25% 21.33B
GENMAB A/S Stock Genmab A/S
-8.49% 18.68B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.33% 16.6B
BEIGENE, LTD. Stock BeiGene, Ltd.
-21.39% 14.52B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.97% 14.09B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+21.99% 10.99B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. VLA Stock